A new compound called CMX410 may change the fight against tuberculosis. It targets a weak point in the bacteria’s defenses, even in drug-resistant forms of the disease. Created using a cutting-edge chemistry method, the drug shows promise for being both powerful and safe. Scientists believe it could lead to shorter, more effective treatments for millions of people.
